Search
GSK plc
GSKAdd to Watchlist
50.670USD
-1.480-2.84%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
103.25BMarket Cap
13.06P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
HIV
10.12B
23.53%
Respiratory
9.31B
21.64%
Immuno-inflammation
5.02B
11.66%
Shingles
4.69B
10.89%
Established Vaccines
4.11B
9.55%
Other
9.78B
22.73%
By RegionUSD
Name
Revenue
Proportion
US
22.20B
51.61%
Rest of world
10.90B
25.33%
Europe
9.92B
23.06%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
HIV
10.12B
23.53%
Respiratory
9.31B
21.64%
Immuno-inflammation
5.02B
11.66%
Shingles
4.69B
10.89%
Established Vaccines
4.11B
9.55%
Other
9.78B
22.73%
